Gene · 11277
Papers2,317
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,317
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer. | Ann Med | 2026 | 41869709 | PubTator, text mining | PubMed |
| Retinal Vasculopathy in Inflammatory Cerebral Amyloid Angiopathy: A Case Report of Peripheral Marker of Treatment Response. | Case Rep Ophthalmol | 2026 | 41869556 | PubTator, text mining | PubMed |
| Dynamic changes in TREX1 and LGALS9 mRNA levels in PBMCs predict HBsAg clearance and treatment responses to Peg-IFN-α therapy in HBeAg-negative chronic hepatitis B patients. | Virol J | 2026 | 41866580 | PubTator, text mining | PubMed |
| ER-tethering directs TREX1 penetration of a BAF-dependent barrier at micronuclei. | Mol Cell | 2026 | 41861785 | PubTator, text mining | PubMed |
| Integration of immunogenic cell death in the treatment landscape of non-small cell lung cancer: harnessing the power of the immune system. | Cell Death Discov | 2026 | 41851096 | PubTator, text mining | PubMed |
| Aicardi-Goutières Syndrome: Insights from a Middle Eastern Case Series. | AJNR Am J Neuroradiol | 2026 | 41839614 | PubTator, text mining | PubMed |
| Abscopal effect induced by conventional fractionated radiotherapy following anti-PD-1 immunotherapy in pulmonary metastatic thymic squamous cell carcinoma: a case report and literature review. | Front Immunol | 2026 | 41789110 | PubTator, text mining | PubMed |
| Two Cases of CLIPPERS-like Syndrome Sharing a Hypomorphic UNC13D Variant. | J Clin Immunol | 2026 | 41781714 | PubTator, text mining | PubMed |
| PXL: a Nucleic Acid-Binding Module of Promyelocytic Leukemia Protein. | bioRxiv | 2026 | 41756868 | PubTator, text mining | PubMed |
| Development of a competitive immunoassay platform for quantifying the oligonucleotide products of nucleotide excision repair in UV-irradiated cells. | Nucleic Acids Res | 2026 | 41755631 | PubTator, text mining | PubMed |
| Maintaining Genome Integrity: Actin Polymerization Stabilizes Chromatin Bridges in Cytokinesis. | Int J Mol Sci | 2026 | 41752129 | PubTator, text mining | PubMed |
| The Impact of Genetics on Pediatric Interstitial Lung Diseases: A Narrative Literature Review and Clinical Implications. | Biomedicines | 2026 | 41751284 | PubTator, text mining | PubMed |
| The Role of Non-LTR Retrotransposons in Sterile Inflammation: Mechanisms and Therapeutic Potential. | Biomedicines | 2026 | 41751171 | PubTator, text mining | PubMed |
| Increasing the Response of Mismatch Repair Proficient Rectal Cancer to Immunotherapy with Particle Radiation and DNA Damage Response Inhibitors-Preclinical Evidence. | Cancers (Basel) | 2026 | 41749935 | PubTator, text mining | PubMed |
| Human ISG15 deficiency unveils impaired healing of ulcerations via type I interferon-mediated fibrosis. | J Hum Immun | 2026 | 41743834 | PubTator, text mining | PubMed |
| Biochemical Engineering Perspective on cGAS: From Enzyme Discovery to Potential Industrial Application. | Chembiochem | 2026 | 41738955 | PubTator, text mining | PubMed |
| Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy. | Innovation (Camb) | 2026 | 41737316 | PubTator, text mining | PubMed |
| From local control to immune modulation: hypofractionated radiotherapy as a backbone for cancer immunotherapy. | Front Oncol | 2026 | 41727645 | PubTator, text mining | PubMed |
| The tumor microenvironment in leukemia: molecular pathways of immune evasion. | Front Immunol | 2026 | 41727472 | PubTator, text mining | PubMed |
| Synergistic effects of radiotherapy and immunotherapy: improving oncological outcomes. | Front Immunol | 2026 | 41716387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11277/papers?page=2